Saturday, 19 September 2020

Drug Controller Approves Commercial Launch Of Low Cost Covid Test Feluda

The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...

from NDTV News - Topstories https://ift.tt/2FMnI1j
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Loan Fraud Convict's 'Catch Me If You Can' Of 4 Decades Ends, Courtesy CBI

He has been on the run for 47 years in a Rs 5.69 lakh bank fraud case filed by the Central Bureau of Investigation in 1978. Over four decade...